Brief: Palvella Therapeutics Appoints Matthew Korenberg As Chief Financial Officer
17/10/2024 12:37
Oct 17 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* PALVELLA THERAPEUTICS APPOINTS MATTHEW E. KORENBERG AS
CHIEF
FINANCIAL OFFICER
Source text for Eikon: ID:nGNX2jGCc3
Further company coverage: LGND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs